| Favipiravir |
法匹拉韦 |
259793-96-9 |
| Sparsentan (RE-021) |
4'-[(2-丁基-4-氧代-1,3-二氮杂螺[4.4]壬-1-烯-3-基)甲基]-N-(4,5-二甲基-3-异恶唑基)-2'-(乙氧基甲基)-[1,1'-联苯]-2-磺酰胺 |
254740-64-2 |
| CarbaMic acid, N-[(1S)-3-Methyl-1-[[(2R)-2-Methyl-2-oxiranyl]carbonyl]butyl]-, 1,1-diMethylethyl ester |
((1S)-3-甲基-1-(((2R)-2-甲基环氧乙基)羰基)丁基)氨基甲酸叔丁酯 |
247068-82-2 |
| Fimasartan |
非马沙坦 |
247257-48-3 |
| Bardoxolone |
2-氰基-3,12-二氧代齐墩果-1,9-二烯-28-酸 |
218600-44-3 |
| S-(2-BORONOETHYL)-L-CYSTEINE HYDROCHLORIDE |
BEC HCL, 一个竞争性的 ARGINASE II抑制剂 |
222638-67-7 |
| 2-(4-MESYLPHENYL)-1-(6-METHYLPYRIDIN-3-YL)- ETHAN-1-ONE |
2-(4-甲磺酰基苯基)-1-(6-甲基吡啶-3-基)-乙酮 |
221615-75-4 |
| 3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE-7-CARBOXYLIC ACID |
3-氧代-3,4-二氢-2H-1,4-苯并恶嗪-7-羧酸 |
214848-62-1 |
| GSK2982772 |
GSK2982772 |
1622848-92-3 |
| BQR695 |
BQR695 |
1513879-21-4 |
| A-1331852 |
A-1331852 |
1430844-80-6 |
| N-((4-(4-phenylpiperazin-1-yl)tetrahydro-2H-pyran-4-yl)methyl)-2-(phenylthio)nicotinamide |
N-[[4-(4-PHENYLPIPERAZIN-1-YL)OXAN-4-YL]METHYL]-2-PHENYLSULFANYLPYRIDINE-3-CARBOXAMIDE |
1428327-31-4 |
| LMK-235 |
N-[[6-(羟基氨基)-6-氧代己基]氧基]-3,5-二甲基-苯甲酰胺 |
1418033-25-6 |
| (E)-N-hydroxy-4-methoxy-2-(biphenyl-4-yl)cinnamamide |
MDK-7933 |
1417997-93-3 |
| GSK J4 HCl |
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯 |
1373423-53-0 |
| TUG 891 |
TUG 891 |
1374516-07-0 |
| Upadacitinib |
乌帕替尼 |
1310726-60-3 |
| ML167 |
5-[4-[[(5-甲基-2-呋喃基)甲基]氨基]-6-喹唑啉基]-2-呋喃甲醇 |
1285702-20-6 |
| NSI-189 |
[2-[(3-甲基丁基)氨基]-3-吡啶基][4-(苯基甲基)-1-哌嗪基]甲酮 |
1270138-40-3 |
| EAI-045 |
EAI-045 |
1942114-09-1 |
